Potassium channel modulator, composition and application
AssigneeNeushen Therapeutics (Shanghai) Co., Ltd
InventorsMiao HU, Yizhe WU, Xingguo LIU, Xinglu ZHOU
Life of this patent
Estimating the term…
Abstract
Disclosed in the present invention is a compound having a structure shown in general formula I, or a stereoisomer thereof, a pharmaceutically acceptable salt thereof, or a solvate thereof. Further disclosed in the present invention are a composition comprising the compound, a preparation and an application. The compound of the present invention has a significant activation effect on KCNQ2/3 potassium ions, and can be used for treating diseases related to potassium channel ion flow, especially for treating central nervous system diseases.
Claims20
A compound, wherein the compound has a structure shown in general formula I:
- or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof;
- wherein
- ring A is a benzene ring or a 5- to 8-membered heterocycle containing 1 to 2 heteroatoms selected from N, O, or S;
- R1 is selected from hydrogen, halogen, C1-C8 alkyl, C1-C8 alkoxy, C2-C8 alkenyl, C2-C8 alkenoxy, 3- to 12-membered spiroalkyl, C3-C8 cycloalkyl, C3-C8 cycloalkoxy, C2-C8 heterocycloalkyl, C2-C8 heterocycloalkoxy, C1-C8 alkylthio, C1-C8 alkanoyl, C1-C8 alkylsulfonyl, aminosulfonyl, halo C1-C8 alkyl, halo C1-C8 alkoxy, halo C2-C8 alkenoxy, halo C3-C8 cycloalkyl, halo C3-C8 cycloalkoxy, halo C2-C8 heterocycloalkyl, halo C2-C8 heterocycloalkoxy, and the alkyl, alkoxy, alkenyl, alkenoxy, cycloalkyl, cycloalkoxy, heterocycloalkyl, heterocycloalkoxy, alkylthio, alkanoyl, alkylsulfonyl, aminosulfonyl are unsubstituted or substituted by R8;
- each R2 is independently selected from hydrogen, halogen, C1-C8 alkyl, C1-C8 alkoxy, C3-C8 cycloalkyl, C3-C8 cycloalkoxy, C2-C8 heterocycloalkyl, C2-C8 heterocycloalkoxy, halo C1-C8 alkyl, halo C1-C8 alkoxy, halo C3-C8 cycloalkyl, halo C3-C8 cycloalkoxy, halo C2-C8 heterocycloalkyl, halo C2-C8 heterocycloalkoxy;
- or two R2 groups are attached to the same atom, and the two R2 groups are different or the same, and the two R2 groups, together with the atom to which they are attached, form a 3- to 6-membered cycloalkyl ring or a 3- to 6-membered heterocycle;
- R4, R5, R6, R7, R8 are each independently selected from hydrogen, halogen, C1-C8 alkyl, C1-C8 alkoxy, C3-C8 cycloalkyl, C3-C8 cycloalkoxy, C2-C8 heterocycloalkyl, C2-C8 heterocycloalkoxy, halo C1-C8 alkyl, halo C1-C8 alkoxy, halo C3-C8 cycloalkyl, halo C3-C8 cycloalkoxy, halo C2-C8 heterocycloalkyl, halo C2-C8 heterocycloalkoxy, 3- to 12-membered spiroalkyl;
- n is selected from 0, 1, 2;
- m is selected from 0, 1, 2, 3, 4, 5;
- X1 and X2 are each independently selected from —CRaRb, —NRa, —O—, —C(O)—, —S—, —S(O)—, —S(O)2—;
- Ra and Rb are each independently selected from hydrogen, halogen, hydroxyl, amino, C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkylamino, C3-C8 cycloalkyl, halo C1-C8 alkyl, halo C1-C8 alkoxy, halo C3-C8 cycloalkyl;
- indicates the presence or absence of a chemical bond;
- Z is selected from O or (CH2)p, and p is an integer of 1 to 6;
- R3 is C1-C8 alkyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, C2-C8 alkenyl, or C2-C8 alkynyl, wherein the C1-C8 alkyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, C2-C8 alkenyl, or C2-C8 alkynyl is unsubstituted or substituted by one or more than one substituent selected from halogen, nitro, cyano, amino, or hydroxyl.
Dependencies are inferred from the claim text.